Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder
The purpose of this study aims to investigate the utility of Pivotal Response Treatment (PRT), a behaviorally derived intervention, to improve the quality and frequency of communication and social engagement of toddlers with siblings who have an autism spectrum disorder (SIBS - ASD) and who demonstrate developmental delays and impairments in social interaction between 12 and 15 months of age.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder|
- Feasibility of a novel behavioral treatment [ Time Frame: 24 months ] [ Designated as safety issue: No ]
Assessment of Outcome:
Attendance. Attendance to parent education sessions will be recorded by the therapist.
Parent utilization. To assess the acceptability of the PRT approach, parents will be asked to keep a weekly log of procedure use, including overall estimated duration and choice of activities.
- Acceptability of a novel behavioral treatment [ Time Frame: 24 months ] [ Designated as safety issue: No ]
Assessment of Outcome:
Parent satisfaction. At post-treatment, parents will be asked to complete a Likert-scale and short response questionnaire rating their satisfaction with various aspects of the program
|Study Start Date:||September 2012|
|Estimated Study Completion Date:||September 2015|
|Primary Completion Date:||September 2014 (Final data collection date for primary outcome measure)|
Experimental: Infant Toddler Years PRT
Infant Toddler PRT in an evidence-based, manualized treatment for children with autism spectrum disorder that involves specific motivational behavioral procedures adapted to be developmentally appropriate for 12-15 month old infants who present with developmental delays.
Behavioral: Infant Toddler Years PRT
Other Name: Pivotal Response Treatment
No Intervention: Community Treatment
Community Treatment includes the treatments offered by early intervention services (e.g., speech-language therapy, special education instruction).
Please refer to this study by its ClinicalTrials.gov identifier: NCT01691066
|United States, Connecticut|
|Yale Child Study Center|
|New Haven, Connecticut, United States, 06510|
|Principal Investigator:||Katarzyna Chawarska, PhD||Yale University|